Polo Ralph Lauren Corporation (RL) Company Profile
Ralph Lauren Corporation, together with its subsidiaries, engages in the design, marketing, and distribution of lifestyle products. The company offers men?s, women?s, and children?s clothing; and accessories comprising footwear, eyewear, watches, jewelry, hats, and belts, as well as leather goods, including handbags and luggage. It also provides products for homes, including bedding and bath products, furniture, fabric and wallpaper, paint, tabletop, and giftware; and fragrance products for women men. In addition, the company licenses its products, such as men?s sportswear, men?s tailored clothing, men?s underwear and sleepwear, eyewear, fragrances, cosmetics, and color and skin care products. It offers its products under the Polo by Ralph Lauren, Ralph Lauren Purple Label, Ralph Lauren Women?s Collection, Black Label, Blue Label, Lauren by Ralph Lauren, RRL, RLX, Rugby, Ralph Lauren Childrenswear, American Living, Chaps, and Club Monaco brand names. Ralph Lauren sells its products to department stores, specialty stores, and golf and pro shops; full-price retail stores, factory retail stores, and concessions-based shop-within-shops; and online through RalphLauren.com and Rugby.com. As of April 3, 2010, it operated 179 full-price retail stores and 171 factory stores worldwide, as well as 281 concessions-based shop-within-shops and 2 e-commerce Websites. The company was formerly known as Polo Ralph Lauren Corporation and changed its name to Ralph Lauren Corporation in August 2011. Ralph Lauren Corporation was founded in 1967 and is based in New York, New York.
News about RL
Arrowhead Pharmaceuticals - Pullbacks Are Becoming Rare, So Take Advantage If You Love The Potential
Arrowhead Pharmaceuticals (ARWR) has had a terrific run this last year as it has fully turned the corner from its DPC platform crash and has flourished under its new TRiM platform. Its lead programs might be able to progress through the clinic quicke...Read More>>>
Biogen: High Competitive Threats, But A Promising Pipeline
Biogen Inc. (BIIB) is a global biotechnology giant which has a history of creating good shareholder value through many successful drug launches. The management is recently struggling with competitive threats in the multiple sclerosis segment and also...Read More>>>
Treasure Hunting In The OTC Market
Background Even after the recent sell-off in US stocks, the market still looks expensive by many metrics, including the Warren Buffett Indicator now telling you not to bet on America... well, at least not to bet solely on America. Even currently over...Read More>>>
A Buyable Dip In Cognex?
Being a value-oriented investor who loves technology, particularly industrial technology, often has me feeling like a stranger in a strange land. There’s never any shortage of “you can’t worry about valuation; you just have to buy!” comments,...Read More>>>
2 Catalysts That Could Drive The Price Of Celsius Holdings Much Higher In The Short Run
The last time we wrote about shares of Celsius Holdings, Inc. (CELH) was back in September of 2017. We still believe today, as we did back then, that shares of CELH remain overvalued on a Price-to-Sales metric. The company has made substantial progre...Read More>>>